Background: High-risk human papillomavirus (HR-HPV) testing has become a preferred
cervical cancer screening strategy in some countries due to its superior sensitivity over …

High‐risk human papillomavirus (hrHPV) testing has a higher sensitivity but lower specificity
than cytology for detection of high‐grade intraepithelial neoplasia (CIN). To avoid over …

We studied whether triage of human papillomavirus (HPV)‐positive women participating in
an HPV‐based screening programme can be improved by including the HPV result at the …

Objective While cytology-based screening programs have significantly reduced mortality
and morbidity from cervical cancer, the global consensus is that primary human …

Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

Although cytology‐based screening programs have significantly reduced mortality and
morbidity from cervical cancer, the global consensus is that primary human papillomavirus …

A main challenge of human papilloma (HPV)‐based screening for cervical cancer is to
adequately identify HPV‐positive women at highest risk of cervical intraepithelial neoplasia …

Objectives ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer
in women≥ 25 years. This reports the 3-year end-of-study results comparing the …

HPV testing is more sensitive than cytology for cervical screening. However, to incorporate
HPV tests into screening, risk‐stratification (“triage”) of HPV‐positive women is needed to …

Objectives While cervical cytology is accepted triage for human papillomavirus (HPV)–
positive women, the efficiency of cervical screening could be improved by exploiting disease …